The number of tuberculosis-related deaths in Japan, not associated with HIV, is forecasted to decline slightly from 3.5 thousand in 2024 to 3.44 thousand in 2028. This reflects an overall reduction pattern from previous years, indicating consistent health improvements and effective disease management. Compared to 2023, the year-on-year variation shows a minor decline annually, averaging a CAGR of approximately -0.34% over five years. These figures highlight a gradual but positive trend in public health outcomes related to tuberculosis in Japan.
Going forward, critical trends to monitor include advancements in medical treatments, the impact of public health policies, and the potential emergence of drug-resistant strains that could alter mortality forecasts. Additionally, socioeconomic factors and healthcare accessibility will play significant roles in shaping future tuberculosis management.
